6-11714494-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032744.4(ADTRP):c.677G>A(p.Arg226Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032744.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADTRP | NM_032744.4 | c.677G>A | p.Arg226Gln | missense_variant | 6/6 | ENST00000414691.8 | NP_116133.1 | |
ADTRP | NM_001143948.2 | c.731G>A | p.Arg244Gln | missense_variant | 7/7 | NP_001137420.1 | ||
ADTRP | XM_011514956.2 | c.*15G>A | 3_prime_UTR_variant | 7/7 | XP_011513258.1 | |||
ADTRP | XM_047419420.1 | c.*15G>A | 3_prime_UTR_variant | 7/7 | XP_047275376.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADTRP | ENST00000414691.8 | c.677G>A | p.Arg226Gln | missense_variant | 6/6 | 1 | NM_032744.4 | ENSP00000404416.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000764 AC: 19AN: 248702Hom.: 0 AF XY: 0.0000817 AC XY: 11AN XY: 134676
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461420Hom.: 0 Cov.: 34 AF XY: 0.0000179 AC XY: 13AN XY: 727022
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74406
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at